MedPath

山东辉成药业有限公司

Ownership
-
Established
2022-03-04
Employees
-
Market Cap
-
Website
huichengyaoye.cn

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

65

NMPA:65

Drug Approvals

Ambroxol Hydrochloride Solution for Inhalation

Product Name
吸入用盐酸氨溴索溶液
Approval Number
国药准字H20253466
Approval Date
Feb 25, 2025
NMPA

Ambroxol Hydrochloride Solution for Inhalation

Product Name
吸入用盐酸氨溴索溶液
Approval Number
国药准字H20253465
Approval Date
Feb 25, 2025
NMPA

Vitamin B6 Injection

Product Name
维生素B6注射液
Approval Number
国药准字H37020680
Approval Date
Aug 18, 2021
NMPA

Armillarisin A Injection

Product Name
亮菌甲素注射液
Approval Number
国药准字H37024037
Approval Date
Aug 18, 2021
NMPA

Vitamin B1 Injection

Product Name
维生素B1注射液
Approval Number
国药准字H37020678
Approval Date
Aug 18, 2021
NMPA

Vitamin B1 Injection

Product Name
维生素B1注射液
Approval Number
国药准字H37020677
Approval Date
Aug 18, 2021
NMPA

Vitamin B12 Injection

Product Name
维生素B12注射液
Approval Number
国药准字H37020400
Approval Date
Aug 18, 2021
NMPA

Vitamin B12 Injection

Product Name
维生素B12注射液
Approval Number
国药准字H37020695
Approval Date
Aug 18, 2021
NMPA

Vitamin B12 Injection

Product Name
维生素B12注射液
Approval Number
国药准字H37020401
Approval Date
Aug 18, 2021
NMPA

Vitamin B12 Injection

Product Name
维生素B12注射液
Approval Number
国药准字H37020402
Approval Date
Aug 18, 2021
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.